ATS Life Sciences
ATS Life Sciences, headquartered in California, is a prominent player in the life sciences industry, specialising in advanced automation solutions and integrated systems for pharmaceutical and biotechnology sectors. Founded in 2001, the company has achieved significant milestones, including the development of innovative technologies that enhance laboratory efficiency and accuracy. With a focus on core services such as laboratory automation, data management, and custom software solutions, ATS Life Sciences stands out for its commitment to quality and precision. The company has established a strong market position, recognised for its expertise in streamlining complex workflows and improving operational outcomes. Through its dedication to innovation and customer satisfaction, ATS Life Sciences continues to lead the way in transforming the landscape of life sciences automation.
DitchCarbon Score
How does ATS Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ATS Life Sciences's score of 11 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ATS Life Sciences's reported carbon emissions
In 2023, ATS Life Sciences reported total carbon emissions of approximately 27,074,570 kg CO2e, encompassing Scope 1, Scope 2, and Scope 3 emissions, each contributing equally to this total. This figure reflects a slight increase from 2022, where emissions were about 24,570,490 kg CO2e. The company has shown a significant reduction in emissions from 2020, which stood at approximately 36,202,590 kg CO2e, indicating a downward trend over the years. Despite these reductions, ATS Life Sciences has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company’s emissions data highlights the importance of ongoing efforts to address carbon footprints within the life sciences sector, particularly in the context of increasing global climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ATS Life Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
